This information is for research and educational purposes only. No medical recommendations. Products are not approved for human use. For health questions, consult a doctor.

Lexicon

PCT & hormone control

Letrozole (Femara)

The most potent aromatase inhibitor - strong enough for gyno reversal, easy to overdose.

1 min read 1 sources Titration Updated June 2026
Class
Aromatase inhibitor (non-steroidal, reversible)
Use
Oral, 1-2x per week
Half-life
about 2-4 days
Status
Clinically approved (breast cancer)

Getting started

Typical dosing (research context)

Per-week figures in mg. Very potent - easy to overdose. Always by blood value.

Members only

Dosing recommendations are visible to logged-in members only. Logging in is free.

Log in / sign up

What is Letrozole?

Letrozole (brand name Femara) is the most potent of the non-steroidal aromatase inhibitors. It lowers estradiol even more strongly than anastrozole - by over 98% in clinical studies. That strength is both advantage and risk: letrozole can reverse active gynecomastia, but also crashes estradiol too low quickly if you are not careful.

This information is for research and educational purposes only. No medical advice.

How it works

Like anastrozole, letrozole binds aromatase reversibly, just much more strongly. The near-complete estradiol suppression makes it the choice when other AIs are not enough - for example with already visible gynecomastia you want to push back.

Dosing

Members only

Dosing recommendations are visible to logged-in members only. Logging in is free.

Log in / sign up

What the research shows

The BIG 1-98 study (NEJM, 2005) compared letrozole with tamoxifen in postmenopausal breast cancer and showed significant superiority of letrozole in disease-free survival. That confirms the very strong estrogen lowering that makes letrozole so potent in research contexts.

Side effects

  • Estradiol crash: the main risk - joint pain, libido loss, lethargy, poor sleep.
  • Lipids: very low estradiol worsens cholesterol markedly.
  • Bone density: relevant with long-term use.

Storage

Store dry and protected from light. Out of reach of children.

Evidence

Sources

  1. 1 Letrozole vs tamoxifen in postmenopausal breast cancer (BIG 1-98). BIG 1-98 Collaborative Group, NEJM, 2005

Keep reading

More in the lexicon

In the shop

Letrozole (Femara) in the catalog

Sizes, prices and availability for research use. Straight from the lexicon to the product page.

View in shop